EUVIMEDEUVIMED entdecken
Crossref

Assessing cancer cell heterogeneity in patient-derived tumoroids

Flora Doffe, Lucile Mercier, Olivia Bawa, Guido Kroemer, Oliver Kepp, Pierre Savagner

Methods in Cell Biology · 2025

DOI: 10.1016/bs.mcb.2025.10.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Flora Doffe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 09 labellisée par la L…. Hauptthemen laut MEDLINE: Organoids, Neoplasms. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Institut Gustave-Roussy, Ligue Contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here we detail a method for the exploration of patient-derived xenografts (PDX) based on organoids (PDX-O), using antibodies validated for immunohistochemistry. Importantly this approach can be used to characterize the response of malignant cells to antineoplastic treatments. Cancer progression and metastasis reflect tumor heterogeneity and plasticity. Here we analyzed cells in PDX grown as spheroids or tumoroids embedded in collagen/basement membrane extract (BME) matrix. The use of 3D cellular models instead of 2D allows the inclusion in the study of non-adherent tumors. Even if the cells are adherent the spheroid and tumoroids conformation or organization in space and cellular polarity differ for 2D. This difference can change the response to treatment. Adding a matrix component is an important addition to the tumoral microenvironment that can change also the cellular response to treatment. We combined this tridimensional model with a multiplexed staining protocol to analyze tumor cell differentiation and responses to drugs. We analyzed paraffin embedded organoid sections, allowing to analyze the core of cell aggregates, and analyzed cell plasticity, differentiation and proliferation with and without treatment with palbociclib. Spheroids included an outer layer of luminal cytokeratin (CK) 8-positive cells surrounding a mixed population of cells expressing both CK5 and CK8. Palbociclib treatment resulted in a proliferation arrest, linked to dedifferentiation of the cancer cells that switched to a mostly basal phenotype, supporting a hybrid CK5/CK8 phenotype. In summary, this method offers a simple and versatile strategy to analyze tumor cell responses to drugs, using routine antibodies validated for immunohistochemistry and multiplex analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeoplasmsHumansSpheroids, CellularAnimalsTumor MicroenvironmentMiceCell ProliferationImmunohistochemistryCell DifferentiationXenograft Model Antitumor AssaysAntineoplastic Agents

Stichwörter der Autor:innen

3D modelCancerMicroenvironmentOrganoidSpectral microscopy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 09 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, P…
  • INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, Villejuif, France.
  • INSERM US23, CNRS UAR 3655, AMMICa, Experimental and Translational Pathology Platform, Gustave Roussy, Villejuif, France.
  • INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, Villejuif, France. Electronic address: Pierre.savagner@inserm.fr.

Förderung

  • Agence Nationale de la Recherche
  • Institut Gustave-Roussy
  • Ligue Contre le Cancer

Zitieren

APA

Doffe, F., Mercier, L., Bawa, O., Kroemer, G., Kepp, O., & Savagner, P. (2025). Assessing cancer cell heterogeneity in patient-derived tumoroids. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2025.10.004

Vancouver

Doffe F, Mercier L, Bawa O, Kroemer G, Kepp O, Savagner P. Assessing cancer cell heterogeneity in patient-derived tumoroids. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2025.10.004

BibTeX
@article{Doffe2025,
  author = {Doffe, Flora and Mercier, Lucile and Bawa, Olivia and Kroemer, Guido and Kepp, Oliver and Savagner, Pierre},
  title = {Assessing cancer cell heterogeneity in patient-derived tumoroids},
  journal = {Methods in Cell Biology},
  year = {2025},
  doi = {10.1016/bs.mcb.2025.10.004}
}
Kostenlos starten →